Skip to content

Commit

Permalink
Merge pull request #115 from OHDSI/improve_vocabulary
Browse files Browse the repository at this point in the history 
update vocabularies
  • Loading branch information
@catalamarti
catalamarti committed Sep 16, 2024
2 parents 8e86fc8 + 33ab5a5 commit c7798d9
Show file tree
Hide file tree
Showing 6 changed files with 763 additions and 37 deletions.
Binary file modified R/sysdata.rda
View file
Binary file not shown.
158 changes: 136 additions & 22 deletions data-raw/default/concept.csv
View file
Original file line number Diff line number Diff line change
@@ -1,23 +1,4 @@
concept_id,concept_name,domain_id,vocabulary_id,standard_concept,concept_class_id,concept_code,valid_start_date,valid_end_date,invalid_reason
1,Musculoskeletal disorder,Condition,SNOMED,S,Clinical Finding,1234,NA,NA,NA
2,Osteoarthrosis,Condition,SNOMED,S,Clinical Finding,1234,NA,NA,NA
3,Arthritis,Condition,SNOMED,S,Clinical Finding,1234,NA,NA,NA
4,Osteoarthritis of knee,Condition,SNOMED,S,Clinical Finding,1234,NA,NA,NA
5,Osteoarthritis of hip,Condition,SNOMED,S,Clinical Finding,1234,NA,NA,NA
6,Osteonecrosis,Condition,SNOMED,S,Clinical Finding,1234,NA,NA,NA
7,Degenerative arthropathy,Condition,Read,NA,Diagnosis,1234,NA,NA,NA
8,Knee osteoarthritis,Condition,Read,NA,Diagnosis,1234,NA,NA,NA
9,H/O osteoarthritis,Observation,LOINC,S,Observation,1234,NA,NA,NA
10,Adalimumab,Drug,RxNorm,S,Ingredient,1234,NA,NA,NA
11,Injection,Drug,OMOP,NA,Dose Form,1234,NA,NA,NA
12,ALIMENTARY TRACT AND METABOLISM,Drug,ATC,NA,ATC 1st,1234,NA,NA,NA
13,Descendant drug,Drug,RxNorm,S,Drug,1234,NA,NA,NA
14,Injectable,Drug,OMOP,NA,Dose Form,1234,NA,NA,NA
15,Diseases of the musculoskeletal system and connective tissue,Condition,ICD10,NA,ICD10 Chapter,1234,NA,NA,NA
16,Arthropathies,Condition,ICD10,NA,ICD10 SubChapter,1234,NA,NA,NA
17,Arthritis,Condition,ICD10,NA,ICD Code,1234,NA,NA,NA
18,OA,Condition,ICD10,NA,ICD Code,1234,NA,NA,NA
19,Other ingredient,Drug,RxNorm,S,Ingredient,1234,NA,NA,NA
38003563,Hispanic or Latino,Ethnicity,Ethnicity,Ethnicity,S,Hispanic,01/01/1970,31/12/2099,NA
38003564,Not Hispanic or Latino,Ethnicity,Ethnicity,Ethnicity,S,Not Hispanic,01/01/1970,31/12/2099,NA
8507,MALE,Gender,Gender,Gender,S,M,01/01/1970,31/12/2099,NA
Expand Down Expand Up @@ -3243,6 +3224,139 @@ concept_id,concept_name,domain_id,vocabulary_id,standard_concept,concept_class_i
9201,Inpatient Visit,Visit,Visit,Visit,S,IP,01/01/1970,31/12/2099,NA
9202,Outpatient Visit,Visit,Visit,Visit,S,OP,01/01/1970,31/12/2099,NA
9203,Emergency Room Visit,Visit,Visit,Visit,S,ER,01/01/1970,31/12/2099,NA
3020630,Protein serum/plasma,Measurement,LOINC,Lab Test,S,2885-2,01/01/1970,31/12/2099,NA
4336464,Coronary artery bypass graft,Procedure,SNOMED,Procedure,S,232717009,01/01/1970,31/12/2099,NA
4295880,Intramuscular injection,Procedure,SNOMED,Procedure,S,76601001,01/01/1970,31/12/2099,NA
194152,Renal agenesis and dysgenesis,Condition,SNOMED,Clinical Finding,S,204938007,37287,73050,NA
437738,Motor vehicle accident off public road,Observation,SNOMED,Event,S,214640008,37287,73050,NA
444074,Victim of vehicular AND/OR traffic accident,Condition,SNOMED,Clinical Finding,S,36198007,37287,73050,NA
1004521,"How often did you drink regular colas and root beer (with caffeine, not diet)",Observation,LOINC,LOINC Component,NA,LP102691-5,25569,73050,NA
1025532,^Patient,Observation,LOINC,LOINC System,NA,LP310005-6,25569,73050,NA
1029636,Finding,Observation,LOINC,LOINC Property,NA,LP6813-2,25569,73050,NA
1029706,Number (count),Observation,LOINC,LOINC Property,NA,LP6841-3,25569,73050,NA
1029816,Point in time (spot),Observation,LOINC,LOINC Time,NA,LP6960-1,25569,73050,NA
1032718,Number of days diuretic medication received,Observation,LOINC,LOINC Component,NA,LP75209-4,25569,73050,NA
1033535,Minimum Data Set,Observation,LOINC,LOINC Method,NA,LP76084-0,25569,73050,NA
1033749,Ord,Observation,LOINC,LOINC Scale,NA,LP7751-3,25569,73050,NA
1033751,Qn,Observation,LOINC,LOINC Scale,NA,LP7753-9,25569,73050,NA
1034443,PhenX,Observation,LOINC,LOINC Method,NA,LP95333-8,25569,73050,NA
1361364,glucagon Nasal Powder,Drug,RxNorm,Clinical Drug Form,S,2180665,43711,73050,NA
1361365,glucagon 3 MG Nasal Powder,Drug,RxNorm,Clinical Drug,S,2180666,43711,73050,NA
1361368,glucagon Nasal Powder [Baqsimi],Drug,RxNorm,Branded Drug Form,S,2180669,43711,73050,NA
1361370,glucagon 3 MG Nasal Powder [Baqsimi],Drug,RxNorm,Branded Drug,S,2180671,43711,73050,NA
1830184,Sisymbrium officianale whole extract 10 MG Nasal Powder [Euphon],Drug,RxNorm Extension,Branded Drug,S,OMOP5155536,44440,73050,NA
1830278,Sisymbrium officianale whole extract Nasal Powder,Drug,RxNorm Extension,Clinical Drug Form,S,OMOP5155532,44440,73050,NA
1830279,Sisymbrium officianale whole extract Nasal Powder [Euphon],Drug,RxNorm Extension,Branded Drug Form,S,OMOP5155533,44440,73050,NA
1830280,Sisymbrium officianale whole extract 10 MG Nasal Powder,Drug,RxNorm Extension,Clinical Drug,S,OMOP5155534,44440,73050,NA
1830281,Sisymbrium officianale whole extract 10 MG Nasal Powder Box of 50,Drug,RxNorm Extension,Clinical Drug Box,S,OMOP5155535,44440,73050,NA
1830282,Sisymbrium officianale whole extract 10 MG Nasal Powder [Euphon] Box of 50,Drug,RxNorm Extension,Branded Drug Box,S,OMOP5155537,44440,73050,NA
1830283,Sisymbrium officianale whole extract 10 MG Nasal Powder [Euphon] Box of 50 by Mayoly Spindler,Drug,RxNorm Extension,Marketed Product,S,OMOP5155538,44440,73050,NA
1971546,glucose / potassium / sodium Nasal Powder,Drug,RxNorm Extension,Clinical Drug Form,S,OMOP5164119,44589,73050,NA
3001467,Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,1777-2,25569,73050,NA
3002069,Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma,Measurement,LOINC,Lab Test,S,15013-6,25569,73050,NA
3011539,Uroporphyrin 3 isomer [Moles/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,14943-5,25569,73050,NA
3012056,Uroporphyrin 3 isomer [Moles/volume] in Urine,Measurement,LOINC,Lab Test,S,14945-0,25569,73050,NA
3018910,Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,17838-4,35961,73050,NA
3026074,Uroporphyrin 3 isomer [Moles/volume] in Stool,Measurement,LOINC,Lab Test,S,14944-3,25569,73050,NA
3026972,Cyclohexanone [Mass/volume] in Urine,Measurement,LOINC,Lab Test,S,21236-5,25569,73050,NA
3041300,Uroporphyrin 3 isomer [Moles/time] in 24 hour Urine,Measurement,LOINC,Lab Test,S,40408-7,25569,73050,NA
3042479,Alkaline phosphatase.bone [Presence] in Serum or Plasma,Measurement,LOINC,Lab Test,S,40797-3,38467,73050,NA
3043879,Number of days diuretic medication received [Minimum Data Set],Observation,LOINC,Survey,S,45840-6,25569,73050,NA
3045657,Days received the following medication Set,Observation,LOINC,Survey,S,46058-4,25569,73050,NA
3046614,Uroporphyrin 3 isomer [Mass/time] in 24 hour Stool,Measurement,LOINC,Lab Test,S,33585-1,25569,73050,NA
3046700,Uroporphyrin 3 isomer [Moles/mass] in Stool,Measurement,LOINC,Lab Test,S,45312-6,25569,73050,NA
3523798,Manic mood,Observation,SNOMED,Undefined,NA,1.86611E+14,25569,38564,U
3583353,Other operation on amniotic cavity NOS,Procedure,SNOMED,Procedure,NA,6.23301E+14,40269,40819,D
4004858,Uroporphyrin III measurement,Measurement,SNOMED,Procedure,S,121272002,37287,73050,NA
4012925,Operation on accessory sinus,Procedure,SNOMED,Procedure,S,112788002,37287,73050,NA
4044177,Measurement - action,Observation,SNOMED,Qualifier Value,S,129266000,37287,73050,NA
4092121,Level of mood,Observation,SNOMED,Observable Entity,S,247774004,37287,73050,NA
4141932,Operation on unspecified nasal sinus,Procedure,SNOMED,Procedure,NA,265029005,37287,44588,U
4150381,Uroporphyrin measurement,Measurement,SNOMED,Procedure,S,31152005,37287,73050,NA
4151660,Alkaline phosphatase bone isoenzyme raised,Condition,SNOMED,Clinical Finding,S,310885000,37287,73050,NA
4154344,Alkaline phosphatase - bone isoenzyme measurement,Measurement,SNOMED,Procedure,S,271052004,37287,73050,NA
4195342,Plasma alkaline phosphatase bone isoenzyme measurement,Measurement,SNOMED,Procedure,S,313846006,37287,73050,NA
4197973,"Alkaline phosphatase bone isoenzyme measurement, serum",Measurement,SNOMED,Procedure,S,313845005,37287,73050,NA
4220473,"Alkaline phosphatase isoenzyme, bone fraction",Drug,SNOMED,Substance,NA,3990003,37287,73050,NA
4220524,Uroporphyrin III,Drug,SNOMED,Substance,NA,82778006,37287,73050,NA
4220699,Alkaline phosphatase isoenzymes measurement,Measurement,SNOMED,Procedure,S,8244002,37287,73050,NA
4226696,Manic mood,Condition,SNOMED,Clinical Finding,S,405273008,38017,73050,NA
4304866,Elevated mood,Condition,SNOMED,Clinical Finding,S,81548002,37287,73050,NA
21018250,Jaaps Health Salts,Drug,RxNorm Extension,Brand Name,NA,OMOP336827,25569,73050,NA
21216049,Sodium potassium tartrate,Drug,dm+d,Ingredient,NA,8088411000001102,25569,73050,NA
21492201,Uroporphyrin 3 isomer [Mass/time] in 24 hour Urine,Measurement,LOINC,Lab Test,S,79128-5,42545,73050,NA
21601213,combinations of electrolytes; parenteral,Drug,ATC,ATC 5th,C,B05XA30,25569,73050,NA
21601386,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,Drug,ATC,ATC 1st,C,L,25569,73050,NA
21601387,ANTINEOPLASTIC AGENTS,Drug,ATC,ATC 2nd,C,L01,25569,73050,NA
35604394,Topical Liquefied Gas,Drug,RxNorm,Dose Form,NA,1788820,42492,73050,NA
35604434,nitrogen Topical Liquefied Gas,Drug,RxNorm,Clinical Drug Form,S,1788944,42492,73050,NA
35604435,nitrogen 99.2 % Topical Liquefied Gas,Drug,RxNorm,Clinical Drug,S,1788945,42492,73050,NA
35604439,nitrogen 99 % Topical Liquefied Gas,Drug,RxNorm,Clinical Drug,S,1788949,42492,73050,NA
35604877,Nasal Powder,Drug,RxNorm,Dose Form,NA,1739329,42492,73050,NA
35604879,sumatriptan Nasal Powder,Drug,RxNorm,Clinical Drug Form,S,1739331,42492,73050,NA
35604880,sumatriptan 11 MG Nasal Powder,Drug,RxNorm,Clinical Drug,S,1739332,42492,73050,NA
35604883,sumatriptan Nasal Powder [Onzetra],Drug,RxNorm,Branded Drug Form,S,1739335,42492,73050,NA
35604884,sumatriptan 11 MG Nasal Powder [Onzetra],Drug,RxNorm,Branded Drug,S,1739337,42492,73050,NA
35741956,Sodium potassium tartrate,Drug,RxNorm Extension,Ingredient,NA,OMOP2800105,25569,43313,U
35774678,POTASSIUM SODIUM TARTRATE / Sodium Bicarbonate / tartaric acid Injectable Solution,Drug,RxNorm Extension,Clinical Drug Form,S,OMOP2776139,42971,73050,NA
36210656,Survey terms not yet categorized,Observation,LOINC,LOINC Hierarchy,C,LP248772-8,25569,73050,NA
40475132,Arthropathies,Condition,ICD10,ICD10 SubChapter,NA,M00-M25,43943,73050,NA
40475135,Other joint disorders,Condition,ICD10,ICD10 SubChapter,NA,M20-M25,43943,73050,NA
40721254,POTASSIUM SODIUM TARTRATE 0.0094 MG/MG,Drug,RxNorm Extension,Clinical Drug Comp,S,OMOP4736855,43255,73050,NA
40741270,POTASSIUM SODIUM TARTRATE / Sodium Bicarbonate / tartaric acid Oral Powder,Drug,RxNorm Extension,Clinical Drug Form,S,OMOP4715651,43255,73050,NA
40764263,"How often did you drink regular colas and root beer (with caffeine, not diet) [PhenX]",Observation,LOINC,Clinical Observation,S,61502-1,40479,73050,NA
40765028,PhenX - caffeine protocol 050301,Measurement,LOINC,Clinical Observation,S,62280-3,40504,73050,NA
40775805,Cyclohexanone,Observation,LOINC,LOINC Component,NA,LP14374-0,25569,73050,NA
45430573,Renal agenesis or dysgenesis NOS,Condition,Read,Read,NA,PD0z.00,25569,73050,NA
45511667,Manic mood,Condition,Read,Read,NA,1S42.00,25569,73050,NA
45533778,Other acquired deformities of limbs,Condition,ICD10,ICD10 Hierarchy,NA,M21,32994,73050,NA
45881662,2-4 times per week,Meas Value,LOINC,Answer,S,LA13846-3,25569,73050,NA
45882429,1-3 times per month,Meas Value,LOINC,Answer,S,LA13836-4,25569,73050,NA
45882430,4-5 times per day,Meas Value,LOINC,Answer,S,LA13856-2,25569,73050,NA
45882431,1 time per week,Meas Value,LOINC,Answer,S,LA13829-9,25569,73050,NA
45882432,2-3 times per day,Meas Value,LOINC,Answer,S,LA13844-8,25569,73050,NA
45882531,6 or more times per day,Meas Value,LOINC,Answer,S,LA13861-2,25569,73050,NA
45883166,5-6 times per week,Meas Value,LOINC,Answer,S,LA13860-4,25569,73050,NA
37498042,Bos taurus catalase preparation,Drug,RxNorm,Ingredient,S,2265847,43955,73050,NA
37787172,Sodium potassium tartrate crystal,Drug,Gemscript,Gemscript,NA,48195020,42461,73050,NA
44091285,POTASSIUM SODIUM TARTRATE 9.4 MG/MG,Drug,RxNorm Extension,Clinical Drug Comp,S,OMOP1085916,42971,73050,NA
44810792,Alkaline phosphatase bone isoenzyme activity measurement,Measurement,SNOMED,Procedure,S,8.89411E+14,41548,73050,NA
44812389,SNOMED CT United Kingdom clinical extension module,Metadata,SNOMED,Model Comp,NA,999000011000000103,38017,44588,D
45548358,Internal derangement of knee,Condition,ICD10,ICD10 Hierarchy,NA,M23,32994,73050,NA
45548372,Other specific joint derangements,Condition,ICD10,ICD10 Hierarchy,NA,M24,32994,73050,NA
45875977,PhenX,Measurement,LOINC,LOINC Class,C,PHENX,25569,73050,NA
45876109,Minimum Data Set (MDS) for Nursing Home Resident Assessment and Care Screening survey,Observation,LOINC,LOINC Class,C,SURVEY.MDS,25569,73050,NA
21603215,THROAT PREPARATIONS,Drug,ATC,ATC 2nd,C,R02,25569,73050,NA
21603248,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,Drug,ATC,ATC 2nd,C,R03,25569,73050,NA
21603365,COUGH AND COLD PREPARATIONS,Drug,ATC,ATC 2nd,C,R05,25569,73050,NA
21603444,ANTIHISTAMINES FOR SYSTEMIC USE,Drug,ATC,ATC 2nd,C,R06,25569,73050,NA
21603530,OTHER RESPIRATORY SYSTEM PRODUCTS,Drug,ATC,ATC 2nd,C,R07,25569,73050,NA
21603812,ENDOCRINE THERAPY,Drug,ATC,ATC 2nd,C,L02,25569,73050,NA
21603848,IMMUNOSTIMULANTS,Drug,ATC,ATC 2nd,C,L03,25569,73050,NA
21603890,IMMUNOSUPPRESSANTS,Drug,ATC,ATC 2nd,C,L04,25569,73050,NA
21605007,RESPIRATORY SYSTEM,Drug,ATC,ATC 1st,C,R,25569,73050,NA
21605008,NASAL PREPARATIONS,Drug,ATC,ATC 2nd,C,R01,25569,73050,NA
36034746,sodium chloride Nasal Powder [Neilmed Sinus Rins],Drug,RxNorm Extension,Branded Drug Form,S,OMOP5044767,44364,73050,NA
36034747,sodium chloride Nasal Powder,Drug,RxNorm Extension,Clinical Drug Form,S,OMOP5044768,44364,73050,NA
36034751,Mentha arvensis top extract / sodium chloride / xylitol Nasal Powder,Drug,RxNorm Extension,Clinical Drug Form,S,OMOP5044772,44364,73050,NA
36036059,glucagon 3 MG Nasal Powder [Baqsimi] by Abacus Medicine,Drug,RxNorm Extension,Marketed Product,S,OMOP5046066,44364,73050,NA
36207527,Clinical terms not yet categorized,Observation,LOINC,LOINC Hierarchy,C,LP248771-0,25569,73050,NA
37065199,Cyclohexanone | Urine | Drug toxicology,Measurement,LOINC,LOINC Hierarchy,C,LP387392-6,25569,73050,NA
40558872,Alkaline phosphatase - bone isoenzyme level,Procedure,SNOMED,Procedure,NA,390317001,25569,37652,U
40563833,Alkaline phosphatase - bone isoenzyme level,Procedure,SNOMED,Procedure,NA,389585009,25569,37652,U
42899580,potassium sodium tartrate,Drug,RxNorm,Ingredient,S,1311363,41183,73050,NA
45538734,"Other joint disorders, not elsewhere classified",Condition,ICD10,ICD10 Hierarchy,NA,M25,32994,73050,NA
37110496,Manic symptoms co-occurrent and due to primary psychotic disorder,Condition,SNOMED,Clinical Finding,S,724758000,42947,73050,NA
44081436,POTASSIUM SODIUM TARTRATE / Sodium Bicarbonate / sodium carbonate / Sodium Chloride / tartaric acid Oral Powder,Drug,RxNorm Extension,Clinical Drug Form,S,OMOP1076067,42971,73050,NA
45755492,Acquired deformities of fingers and toes,Condition,ICD10,ICD10 Hierarchy,NA,M20,32994,73050,NA
45755493,Disorders of patella,Condition,ICD10,ICD10 Hierarchy,NA,M22,32994,73050,NA
45756021,Bus occupant injured in collision with heavy transport vehicle or bus,Condition,ICD10,ICD10 Hierarchy,NA,V74,32994,73050,NA
45756023,"Bus occupant injured in collision with heavy transport vehicle or bus, person on outside of vehicle injured in nontraffic accident",Condition,ICD10,ICD10 code,NA,V74.2,32994,73050,NA
45884448,Never or less than 1 time per month,Meas Value,LOINC,Answer,S,LA13894-3,25569,73050,NA
45885250,1 time per day,Meas Value,LOINC,Answer,S,LA13827-3,25569,73050,NA
36217206,Topical Product,Drug,RxNorm,Dose Form Group,C,1151122,42583,73050,NA
36217213,Nasal Product,Drug,RxNorm,Dose Form Group,C,1151130,42583,73050,NA
37593197,Sodium / Sodium Chloride Nasal Powder,Drug,RxNorm Extension,Clinical Drug Form,S,OMOP4782636,43482,73050,NA
40371897,Manic mood,Condition,SNOMED,Clinical Finding,NA,286571004,37287,38017,D
40642537,Defined,Metadata,SNOMED,Model Comp,NA,900000000000073002,37287,73050,NA
40642538,Primitive,Metadata,SNOMED,Model Comp,NA,900000000000074008,37287,73050,NA
40642539,SNOMED CT core,Metadata,SNOMED,Model Comp,NA,900000000000207008,37287,73050,NA
44022939,Septiline,Drug,RxNorm Extension,Brand Name,NA,OMOP1017570,25569,73050,NA
46274351,sodium potassium tartrate tetrahydrate,Drug,RxNorm,Precise Ingredient,NA,1311362,42255,73050,NA
Loading

0 comments on commit c7798d9

Please sign in to comment.